Cancer stem cells versus phenotype-switching in melanoma.

Cancer stem cells versus phenotype-switching in melanoma.

Tumours comprise multiple phenotypically distinct subpopulations of cells, some of which are proposed to possess stem cell-like properties, being able to self-renew, seed and maintain tumours, and provide a reservoir of therapeutically resistant cells. Here, we use melanoma as a model to explore the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Hoek, K, Goding, C
Format:	Journal article
Idioma:	English
Publicat:	2010

Ítems similars

Connecting metabolic rewiring with phenotype switching in melanoma
per: Falletta, P, et al.
Publicat: (2022)

Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
per: Paola Falletta, et al.
Publicat: (2022-07-01)

SL4/PASPCR Aaron Lerner Lecture Signalling and transcription in melanoma stem-like cells
per: Goding, C
Publicat: (2011)

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities
per: Rambow, F, et al.
Publicat: (2019)

Dendritic cells and melanoma therapy.
per: Goding, C
Publicat: (2009)

Phenotype switching in melanoma: implications for progression and therapy
per: Frederic Zhentao Li, et al.
Publicat: (2015-02-01)

Back to black: Pigment cell and melanoma research
per: Goding, C
Publicat: (2007)

ROR2, a driver of “phenotype switching” in melanoma?
per: Pablo Lopez-Bergami
Publicat: (2022-09-01)

Melanoma: markers and epigenetics
per: Goding, C
Publicat: (2007)

Editorial: melanomas and Wnts.
per: Goding, C
Publicat: (2005)

Melanocyte development and malignant melanoma.
per: Goding, C
Publicat: (2000)

Melanoma, making a difference
per: Goding, C
Publicat: (2007)

Transcription regulation in melanocytes and melanoma
per: Goding, C
Publicat: (2008)

T-box factors in melanocytes and melanoma
per: Goding, C
Publicat: (2008)

Melanoma senescence: HDAC1 in focus.
per: Goding, C
Publicat: (2007)

Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
per: Ken Noguchi, et al.
Publicat: (2017-01-01)

981 AXL-targeted macrophage phenotype switching mediates checkpoint-resistance in melanoma
per: Jessica Fessler, et al.
Publicat: (2023-11-01)

Commentary. A picture of Mitf in melanoma immortality.
per: Goding, C
Publicat: (2011)

Fishful thinking: the rise and fall of MITF in melanoma.
per: Goding, C
Publicat: (2014)

Fishful thinking: the rise and fall of MITF in melanoma.
per: Goding, C
Publicat: (2014)

Commentary. A picture of Mitf in melanoma immortality.
per: Goding, C
Publicat: (2011)

The transcription network regulating melanocyte development and melanoma.
per: Vance, K, et al.
Publicat: (2004)

Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6
per: Patrycja Czerwinska, et al.
Publicat: (2020-01-01)

The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
per: Gaetana Restivo, et al.
Publicat: (2017-12-01)

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
per: Carreira, S, et al.
Publicat: (2006)

Directed phenotype switching as an effective antimelanoma strategy.
per: Sáez-Ayala, M, et al.
Publicat: (2013)

Macrophage cytoplasmic transfer in melanoma invasion
per: Louphrasitthiphol, P, et al.
Publicat: (2017)

Targeting the lncRNA SAMMSON reveals metabolic vulnerability in melanoma
per: Goding, C
Publicat: (2016)

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma
per: Ahmad Najem, et al.
Publicat: (2022-03-01)

Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma
per: Silvia Muccioli, et al.
Publicat: (2023-10-01)

The roles of cancer stem cells and therapeutic implications in melanoma
per: Xiaoli Mu, et al.
Publicat: (2024-11-01)

A distinct octamer-binding protein present in malignant melanoma cells.
per: Cox, P, et al.
Publicat: (1988)

Cancer Cell Phenotype Plasticity as a Driver of Immune Escape in Melanoma
per: Valentin Benboubker, et al.
Publicat: (2022-03-01)

Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma.
per: Jayachandran, A, et al.
Publicat: (2014)

Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage.
per: Goding, C
Publicat: (2000)

Publisher Correction: The low affinity neurotrophin receptor CD271 regulates phenotype switching in melanoma
per: Gaetana Restivo, et al.
Publicat: (2018-01-01)

The Role of Mesenchymal Stem Cells in the Induction of Cancer-Stem Cell Phenotype
per: Yuanming Jing, et al.
Publicat: (2022-02-01)

Flick the cancer stem cells' switch to turn cancer off
per: Christophe Ginestier, et al.
Publicat: (2017-07-01)

MITF and PAX3 play distinct roles in melanoma cell migration; outline of a genetic switch theory involving MITF and PAX3 in proliferative and invasive phenotypes of melanoma
per: Michael R Eccles, et al.
Publicat: (2013-09-01)

The therapeutic implications of plasticity of the cancer stem cell phenotype.
per: Kevin Leder, et al.
Publicat: (2010-12-01)